Streetbeat News

Revenues

NVAX

Novavax has announced an agreement to supply its updated COVID-19 vaccine to private healthcare providers in the United Kingdom. This move could potentially increase the company's vaccine distribution and sales in the UK.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:09 pm

NVMI

Nova (NASDAQ:NVMI) has received multiple orders for its process control solutions tailored for Gate-All-Around (GAA) device manufacturing, covering dimensional, materials, and chemical metrology solutions. These orders, expected to be delivered within the next 12 months, come from leading manufacturers transitioning to GAA technology. Nova's solutions are designed to address the challenges of next-generation device fabrication, providing essential value in geometrical dimensions, materials properties, and chemical analytics. The company anticipates further orders as GAA technology moves into high-volume production.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:04 pm

MSFT

VTSI

VirTra, Inc. (VTSI) has been awarded a $5.9 million prototype contract by the U.S. Army IVAS program, with Microsoft acting as the prime contractor. The contract involves the delivery of bolt kits, magazines, and high-pressure air fill stations, all tailored to the IVAS program's specifications. Revenue recognition from this contract is expected in three phases throughout 2024, encompassing reliability testing, soldier assessment, and final hardware deliveries. This order underscores VirTra's ongoing involvement and commitment to the IVAS program, highlighting its enhanced production capabilities and readiness for mass production to meet the U.S. Army's requirements.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:03 pm

LYFT

Recent analyst ratings for Lyft (NASDAQ:LYFT) show a mix of bullish to bearish sentiments, with a notable upward trend in the 12-month price target to $17.29, reflecting a 20.82% increase from the previous target. Analysts from firms like Tigress Financial, Wells Fargo, and Piper Sandler have raised their price targets and ratings, indicating a positive outlook on Lyft's performance. Despite facing challenges in market capitalization and revenue growth compared to industry peers, Lyft's financial indicators such as net margin, ROE, and ROA outperform industry averages, showcasing strong profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 12:01 pm

PSX

Analysts have recently updated their ratings and price targets for Phillips 66 (NYSE:PSX), showing a mix of bullish and bearish sentiments. The average 12-month price target is now $167.43, up 9.58% from the previous $152.79, indicating an upward trend in expectations. The company's financial performance includes a revenue decline of -4.99% for the last quarter of 2023, a net margin of 3.28%, an ROE of 4.09%, and an ROA of 1.64%, with a debt-to-equity ratio of 0.63.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 12:01 pm

BECN

Beacon Roofing Supply (NASDAQ:BECN) has seen a diverse range of analyst ratings over the last three months, with recent updates indicating a bullish sentiment. The average 12-month price target for BECN has been raised to $121.25, marking a 19.66% increase from the previous target. Financial analysis highlights Beacon Roofing Supply's positive revenue trend with a growth rate of 16.76% as of December 31, 2023, but notes challenges in net margin, ROE, and ROA, despite a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 12:00 pm

MAN

ManpowerGroup (NYSE:MAN) reported Q1 adjusted EPS of $0.94, surpassing the $0.91 estimate, but its sales of $4.40B fell short of the $4.42B estimate. This represents a 41.61% decrease in earnings and a 7.34% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:32 am

CMMB

Chemomab announced a new peer-reviewed publication that supports the clinical association of its CCL24 target with disease severity and mortality in Systemic Sclerosis (SSc). A longitudinal study of over 200 real-world patients further validates CCL24 as a novel target for SSc, indicating its association with disease severity across fibrotic and vascular manifestations of the condition.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:11 am

VNTRD

Vertex Energy anticipates exceeding its Q1 2024 conventional throughput guidance with 64,000 bpd, due to better capacity utilization. Renewable throughput meets expectations, with a significant 28% increase in crack spreads on refined products from Q4 2023. The company also projects an 11% reduction in direct operating expenses and a 29% cut in capital expenditures.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:06 am

IRDM

Iridium Communications (IRDM) has reiterated its FY24 financial outlook, expecting service revenue growth of 4%-6%, OEBITDA of $460M-$470M, cash taxes under $10M through 2026, and a reduction in net leverage to below 2.5 times OEBITDA by end of 2026.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:05 am